Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nicotine-sensitive paresis.

T Yokota1, Y Kagamihara, H Hayashi

  • 1Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan.

Neurology
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

5-HT3 receptor antagonists. 1. New quinoline derivatives.

Journal of medicinal chemistry·1992
Same author

New bronchodilators. II. 3H-imidazo[4,5-c]quinolin-4(5H)-ones.

Chemical & pharmaceutical bulletin·1992
Same author

Site of attachment of mercuribenzoate in crystals of an actin:DNase I complex.

Journal of biochemistry·1992
Same author

Further studies on aspartate aminotransferase of thermophilic methanogens by analysis of general properties, bound cofactors, and subunit structures.

Journal of biochemistry·1992
Same author

Elevated expression of the ornithine decarboxylase gene in human esophageal cancer.

Cancer research·1992
Same author

Experimental chemotherapy for xenograft cell lines of human bile duct and gall bladder cancers in nude mice.

Journal of surgical oncology·1992
Same journal

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.

Neurology·2026
Same journal

Association of Changes in Intrinsic Capacity With Cognitive Decline and Dementia: A Prospective Cohort Study.

Neurology·2026
Same journal

Role of the Upper Motor Neuron in the Generation of Fasciculations in Early Disease Stages of Amyotrophic Lateral Sclerosis.

Neurology·2026
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
See all related articles

Nicotine temporarily worsened epilepsy symptoms like tetraparesis and myoclonus in a patient. The nicotinic antagonist mecamylamine effectively treated these nicotine-induced and spontaneous seizures.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Myoclonus epilepsy is a neurological disorder characterized by involuntary muscle jerks.
  • Nicotine's effects on neurological function, particularly in epilepsy, are not fully understood.

Observation:

  • A patient with myoclonus epilepsy experienced acute tetraparesis and hyperreflexia after smoking a cigarette.
  • Cerebral perfusion increased around the motor cortex, and H-reflex size increased during the paresis.
  • High-nicotine cigarettes induced severe positive and negative myoclonus, alongside tetraparesis.

Findings:

  • Nicotine administration, via smoking or gum, transiently exacerbated epilepsy symptoms, including tetraparesis and myoclonus.
  • Electrophysiological and neuroimaging data indicated altered motor cortex activity and H-reflex potentiation.

Related Experiment Videos

  • Mecamylamine, a nicotinic antagonist, reversed nicotine-induced symptoms and reduced spontaneous myoclonus.
  • Implications:

    • Nicotine acts as a trigger for acute neurological deficits and myoclonus in susceptible individuals with epilepsy.
    • Mecamylamine demonstrates therapeutic potential for managing both nicotine-induced and spontaneous myoclonus in myoclonus epilepsy.
    • Further research into nicotinic acetylcholine receptors in epilepsy is warranted.